Dr. Mohammad Waseem is a cancer biologist who is currently investigating the possible role of drug and/or miRNA therapies in prostate cancer. He is exploring the mechanisms underpinning the therapeutic potential of a novel combination regimen in prostate cancer. In addition, he is also investigating cellular and molecular issues, and conducts exploration of novel strategies and therapeutic challenges with an enriched delivery of the drugs and/or molecules to the impaired cells/tissues of patients with gene-mediated prostate cancer disorder.